glp 1 drugs with insurance How Many Adults Private Health Could Use GLP-1 Why we are changing coverage
Description
p=0.030) and 25% higher at 12 months (95% CI: 2 to 59
The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity
GLP-1 drugs are widely used for diabetes and weight loss, but their potential to transform healthcare is growing
Very few include older adults at high risk
These diet
